Today on DrugResearcher.com   More pharmas implicated in Iraq bribery probe New drug target leaves lung cancer cells alone, lonely and dying A drug cocktail to bust brain tumours IDM Pharma will cut jobs after Sanofi scraps melanoma collaboration New China:US preclinical partnership formed

Related Industry News   Fine Foods extends within pharma Quintiles in $3bn investment deal Merck divests API plant; hands out large contract eClinical news in Brief

Breaking News on Drug Discovery
Daily  Wednesday 02 January 2008		Forward to a colleague

	Access Full Stories More pharmas implicated in Iraq bribery probe While GSK, AstraZeneca and Eli Lilly have hit the headlines in the UK Serious Fraud Office's (SFO) investigation into illegal bribes paid to Saddam Hussein's Iraqi regime, many more pharma firms are on the organisation's... Read New drug target leaves lung cancer cells alone, lonely and dying It seems even tumour cells can get lonely; scientists have discovered that by cutting off a key gene, lung cancer tumour cells are left 'homeless' and they can't survive on their own... Read A drug cocktail to bust brain tumours A team of US researchers have uncovered a cocktail of three drugs that could be effective at treating every patient with a particular type of brain cancer that typically has a dismal prognosis... Read IDM Pharma will cut jobs after Sanofi scraps melanoma collaboration Sanofi-Aventis has decided to pull out of its skin cancer collaboration with IDM Pharma, leaving the Californian biopharma firm considering job cuts as a way to lower costs... Read New China:US preclinical partnership formed US-based MPI Research and China's Shanghai Medicilon have formed a joint venture in preclinical services, as they position themselves to cash in on what is a budding market sector in China... Read
	All News Headlines for: January | December | November
	Related Industry News Fine Foods extends within pharma Italy's Fine Foods has purchased a domestic contract manufacturer operating in the pharmaceutical arena, extending its presence in this industry... Read Quintiles in $3bn investment deal One Equity Partners (OEP), the private equity arm of JPMorgan Chase, is in the process of selling its stake in Quintiles for a reported sum of over $3bn... Read Merck divests API plant; hands out large contract Merck & Co has handed the reins of one of its US active pharmaceutical ingredient (API) manufacturing facilities over to new a owner, who has also secured a lucrative contract manufacturing deal with the drug... Read eClinical news in Brief Outsourcing-Pharma tracks the latest eClinical movements, featuring Medidata, Datatrak and ClinPhone... Read Annual round up of all drugs entering Phase I Small molecules still leading the way into the clinic DrugResearcher.com brings you its annual round up of all the drugs that entered clinical development in 2007. Read Previous Headlines Small molecules still leading the way into the clinic DrugResearcher.com brings you its annual round up of all the drugs that entered clinical development in 2007... Read Biochips help reduce the need for animal testing US researchers have developed a new biochip technology that could dramatically reduce the need for animal testing during drug development safety studies... Read New drug on the blocks for athletes Scientists have discovered a potential new drug target that will prick up the ears of sportsmen and athletes alike. Not that this is an performance-enhancing drug; instead, it could help athletes recover from injury... Read Mapping the 'human embryome' in BioTime BioTimes' subsidiary, Embryome Sciences, is planning to build a relational database that will help identify the hundreds of cell types that can be made from human and mouse embryonic stem cells... Read Pfizer buys CovX to bulk biologics pipeline Pfizer, the world's largest pharma firm, has reached into its pockets to buy CovX, a privately-held US biotech that specialises in combining the strengths of peptides and antibodies into new drugs... Read Technical / White Papers, Case studies, Web casts Benefits of integrating human tissue research in drug discovery - Technical / White Paper Manufacturing Variations in Polysorbate Batches - Technical / White Paper Product Information - brochures, Web centers DAICEL chiral chromatography products - Company Profile Separation of polar compounds - Application Notes Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2008 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com